Consistency: Strong. Deep research (falcon, marked VERIFIED here, cross-checked vs UniProt + cached PMID:18660753), review, PN annotation, and node mapping agree FBXL12 is the SCF(FBXL12) receptor with multiple substrates (p57KIP2/CDKN1C validated IDA PMID:18660753; CAMK1 PMID:23707388; plus falcon leads FANCD2, p27/CDKN1B-K165, ALDH3A1/2, Ku80). No contradictions.
PN story / NEW pressure: PN asserts the generic adaptor MF. FBXL12 GOA has NO MF beyond protein binding. The review adds GO:1990756 as action: NEW (IDA, PMID:18660753) — the batch-correct call, matching the PN-projected new_to_goa term. BPs (SCF catabolism, regulation of cell cycle) already captured. Conclusion: adaptor MF correctly ADDED as NEW; no over-reach.
Mapping strategy: Gene does not change the node. Status/scope right; PN-projected GO:1990756 equals the review MF (not broader/narrower). Has a PMID-validated substrate (p57KIP2 IDA) — canonical receptor, NOT an orphan. Cytoplasmic + nuclear/chromatin dual localization is gene-specific and rightly outside the shared node mapping.
Evidence alignment: PN cites only "15340381/rev"; review uses gene-specific primaries (18660753, 23707388, 33234069) + falcon leads. No overlap with the PN placeholder; review evidence richer. Benign divergence.
Verdict: CONSISTENT / ACCEPT mapping. Correct NEW→GO:1990756 application with a validated substrate anchor. No edits required.